These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 28261825

  • 21. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM, James CA, Te Riele A, Tichnell C, Murray B, Bhonsale A, Kamel IR, Zimmerman SL, Judge DP, Crosson J, Tandri H, Calkins H.
    J Am Heart Assoc; 2017 Jun 06; 6(6):. PubMed ID: 28588093
    [Abstract] [Full Text] [Related]

  • 22. Multicenter experience with transvenous lead extraction in arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Maytin M, Henrikson CA, Schaerf RH, Epstein LM, John RM.
    Pacing Clin Electrophysiol; 2013 Oct 06; 36(10):1280-3. PubMed ID: 23786517
    [Abstract] [Full Text] [Related]

  • 23. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
    Choudhary N, Tompkins C, Polonsky B, McNitt S, Calkins H, Mark Estes NA, Krahn AD, Link MS, Marcus FI, Towbin JA, Zareba W.
    J Cardiovasc Electrophysiol; 2016 May 06; 27(5):555-62. PubMed ID: 26840461
    [Abstract] [Full Text] [Related]

  • 24. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP, Li HR, Chong E, Pan CH, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Lin WY, Shaw KP, Chen SA.
    Heart Rhythm; 2013 Dec 06; 10(12):1859-66. PubMed ID: 24080066
    [Abstract] [Full Text] [Related]

  • 25. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.
    Europace; 2012 Feb 06; 14(2):224-9. PubMed ID: 21946820
    [Abstract] [Full Text] [Related]

  • 26. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
    J Am Coll Cardiol; 2011 Sep 27; 58(14):1485-96. PubMed ID: 21939834
    [Abstract] [Full Text] [Related]

  • 27. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG, Haugaa KH, Bundgaard H, Svensson A, Gilljam T, Hansen J, Madsen T, Holst AG, Carlson J, Lie ØH, Kvistholm Jensen M, Edvardsen T, Jensen HK, Svendsen JH.
    Am J Cardiol; 2019 Apr 01; 123(7):1156-1162. PubMed ID: 30678832
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Canpolat U, Kabakçi G, Aytemir K, Dural M, Sahiner L, Yorgun H, Sunman H, Bariş Kaya E, Tokgözoğlu L, Oto A.
    J Cardiovasc Electrophysiol; 2013 Nov 01; 24(11):1260-6. PubMed ID: 23845044
    [Abstract] [Full Text] [Related]

  • 31. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E, Laredo M, Berruezo A, Gourraud JB, Sellal JM, Martins R, Sacher F, Pison L, Pruvot E, Jáuregui B, Frontera A, Kumar S, Wong T, DellaBella P, Maury P.
    Europace; 2021 Sep 08; 23(9):1428-1436. PubMed ID: 34427302
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2009 Sep 08; 47(3):166-72. PubMed ID: 19604708
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D.
    Circulation; 2004 Mar 30; 109(12):1503-8. PubMed ID: 15007002
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.